Targeted treatment for sonic hedgehog-dependent medulloblastoma

Por Kieran, Mark W.
Publicado em 2014

The VEGF Pathway in Cancer and Disease: Responses, Resistance, and the Path Forward

Por Kieran, Mark W., Kalluri, Raghu, Cho, Yoon-Jae
Publicado em 2012

New Strategies in Pediatric Gliomas: Molecular Advances in Pediatric Low-Grade Gliomas as a Model

Por Raabe, Eric, Kieran, Mark W., Cohen, Kenneth J.
Publicado no Clin Cancer Res (2013)

PPARs: A Double-Edged Sword in Cancer Therapy?

Por Panigrahy, Dipak, Kaipainen, Arja, Kieran, Mark W., Huang, Sui
Publicado em 2008

Future Clinical Trials in DIPG: Bringing Epigenetics to the Clinic

Por Morales La Madrid, Andres, Hashizume, Rintaro, Kieran, Mark W.
Publicado no Front Oncol (2015)

The decision‐making process and criteria in selecting candidate drugs for progeria clinical trials

Por Gordon, Leslie B, Kieran, Mark W, Kleinman, Monica E, Misteli, Tom
Publicado no EMBO Mol Med (2016)

Role of Collagen Matrix in Tumor Angiogenesis and Glioblastoma Multiforme Progression

Por Mammoto, Tadanori, Jiang, Amanda, Jiang, Elisabeth, Panigrahy, Dipak, Kieran, Mark W., Mammoto, Akiko
Publicado em 2013

NS-26 THE ROLE OF SURGERY IN NON-NF-ASSOCIATED PEDIATRIC OPTIC PATHWAY GLIOMAS (OPG) - IS THERE A NEW PARADIGM?

Por Lohkamp, Laura-Nanna, Manley, Peter, Kieran, Mark W., Ullrich, Nicole, Goumnerova, Liliana C.
Publicado no Neuro Oncol (2016)

Initial Cutaneous Manifestations of Hutchinson-Gilford Progeria Syndrome

Por Rork, Jillian F., Huang, Jennifer T., Gordon, Leslie B., Kleinman, Monica, Kieran, Mark W., Liang, Marilyn G.
Publicado em 2014

Development of a Parent-Report Cognitive Function Item Bank Using Item Response Theory and Exploration of its Clinical Utility in Computerized Adaptive Testing

Por Lai, Jin-Shei, Butt, Zeeshan, Zelko, Frank, Cella, David, Krull, Kevin R., Kieran, Mark W., Goldman, Stewart
Publicado em 2011

Inhibition of tumor angiogenesis by oral etoposide

Por PANIGRAHY, DIPAK, KAIPAINEN, ARJA, BUTTERFIELD, CATHERINE E., CHAPONIS, DEVINEY M., LAFORME, ANDREA M., FOLKMAN, JUDAH, KIERAN, MARK W.
Publicado em 2010

PPARα Deficiency in Inflammatory Cells Suppresses Tumor Growth

Por Kaipainen, Arja, Kieran, Mark W., Huang, Sui, Butterfield, Catherine, Bielenberg, Diane, Mostoslavsky, Gustavo, Mulligan, Richard, Folkman, Judah, Panigrahy, Dipak
Publicado em 2007

Parent-perceived child cognitive function: results from a sample drawn from the US general population

Por Lai, Jin-Shei, Zelko, Frank, Butt, Zeeshan, Cella, David, Kieran, Mark W., Krull, Kevin R., Magasi, Susan, Goldman, Stewart
Publicado em 2010

Bone Density in Post-Pubertal Adolescent Survivors of Childhood Brain Tumors

Por Cohen, Laurie E., Gordon, Joshua H., Popovsky, Erica Y., Sainath, Nina N., Feldman, Henry A., Kieran, Mark W., Gordon, Catherine M.
Publicado em 2011

Pediatric low-grade gliomas: How modern biology reshapes the clinical field

Por Bergthold, Guillaume, Bandopadhayay, Pratiti, Bi, Wenya Linda, Ramkissoon, Lori, Stiles, Charles, Beroukhim, Rameen, Ligon, Keith L., Grill, Jacques, Kieran, Mark W.
Publicado em 2014

Prognostic value of tumor microinvasion and metalloproteinases expression in intracranial pediatric ependymomas

Por Snuderl, Matija, Chi, Susan N., De Santis, Stacia M., Stemmer-Rachamimov, Anat O., Betensky, Rebecca A., De Girolami, Umberto, Kieran, Mark W.
Publicado em 2008

Phase II trial of temsirolimus in children with high-grade glioma, neuroblastoma and rhabdomyosarcoma()

Por Geoerger, Birgit, Kieran, Mark W., Grupp, Stephan, Perek, Danuta, Clancy, Jill, Krygowski, Mizue, Ananthakrishnan, Revathi, Boni, Joseph P., Berkenblit, Anna, Spunt, Sheri L.
Publicado em 2011

Impact of Farnesylation Inhibitors on Survival in Hutchinson-Gilford Progeria Syndrome

Por Gordon, Leslie B., Massaro, Joe, D'Agostino, Ralph B., Campbell, Susan E., Brazier, Joan, Brown, W. Ted, Kleinman, Monica E, Kieran, Mark W.
Publicado em 2014

Phase II study of cilengitide in the treatment of refractory or relapsed high-grade gliomas in children: A report from the Children's Oncology Group

Por MacDonald, Tobey J., Vezina, Gilbert, Stewart, Clinton F., Turner, David, Pierson, Christopher R., Chen, Lu, Pollack, Ian F., Gajjar, Amar, Kieran, Mark W.
Publicado em 2013

A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors

Por Rubin, Joshua B., Kung, Andrew L., Klein, Robyn S., Chan, Jennifer A., Sun, YanPing, Schmidt, Karl, Kieran, Mark W., Luster, Andrew D., Segal, Rosalind A.
Publicado em 2003